Press Digest: Wall Street Journal - Sept 27

Filana Therapeutics

27/09/2024 06:00

Sept 27 (Reuters) - The following are the top stories in
the Wall Street Journal. Reuters has not verified these stories
and does not vouch for their accuracy.
    
    - U.S. antitrust enforcers are set to bar Hess  HES.N  CEO
John Hess from joining the board of Chevron  CVX.N  as part of a
deal to approve a $53 billion tie-up between Hess and Chevron.
    
    - Accident investigators with the National Transportation
Safety Board on Thursday urged the Federal Aviation
Administration and Boeing  BA.N  to address a potential hazard
on about 350 of Boeing's 737 models currently flying.
    
    - DirecTV is in advanced talks to acquire its satellite-TV
rival Dish  DISH.MX  and a deal could be finalized as soon as
Monday.
    
    - The U.S. FDA approved Bristol-Myers Squibb's  BMY.N 
schizophrenia drug Cobenfy, also known as KarXT, on Thursday.
    
    - Alzheimer's drug developer Cassava Sciences  SAVA.O  on
Thursday agreed to pay $40 million to settle regulatory claims
that it misled investors about the results of a clinical trial
that showed promise for its drug Simufilam.
    
    - Newsmax said it has settled a lawsuit brought by
Smartmatic over false claims that the voting-technology company
helped rig the 2020 presidential election.

 (Compiled by Bengaluru newsroom)
 ((globalnewsmonitoring@thomsonreuters.com))